Drug Profile
Research programme: Tie-2 inhibitors - Abbott
Alternative Names: Tie-2 pathway inhibitors research programme - AbbottLatest Information Update: 02 Apr 2003
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class
- Mechanism of Action Angiogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 02 Apr 2003 No development reported - Preclinical for Solid tumours in USA (unspecified route)
- 14 Aug 2001 Preclinical development for Solid tumours in USA (Unknown route)